AREV Life Sciences Global Corp. AREVF
0.00 USD 0.00 (+0.00%)
Regular-session close
0.01 Day range 0.01
0.0005 52-week range 0.01
- YTD
- 0.00%
- 1 year
- -95.00%
News
globenewswire.com AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021
globenewswire.com AREV Announces Brian Cameron as Chief Financial Officer VANCOUVER, British Columbia, Sept. 02, 2021 (GLOBE NEWSWIRE) -- AREV LIFE SCIENCES GLOBAL CORP. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce Brian Cameron as Chief…
globenewswire.com AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB VANCOUVER, British Columbia, July 29, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announces that the Company has entered into a collaborative…
globenewswire.com Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation VANCOUVER, British Columbia , July 22, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company's RUTF product…
globenewswire.com AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director Appoints Mel Maxwell as an AREV Director
globenewswire.com AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc. VANCOUVER, British Columbia, July 06, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company has established a wholly…
globenewswire.com AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce…
globenewswire.com AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce that its Chief Executive Officer,…
globenewswire.com AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV”) is pleased to announce the appointment of Dr. Harold C. Smith to its…
globenewswire.com AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (”AREV” or the “Company”) is pleased to announce it has expanded its extraction…
globenewswire.com AREV Nanotec Board of Directors Welcomes Kevin Phelps VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to…
